The glucagon-like peptide-1 (GLP-1)receptor, known asGLP-1R, is a vital component of the G protein-coupledreceptor(GPCR) family and is found primarily on the surfaces of various cell types within the human body. Thisreceptorspecifically ...
This includes integrating the latest clinical trial data and delving into potentialsignalingpathwaysandpharmacological mechanisms.
GLP-1receptor(GLP-1R) is a class B G-protein-coupledreceptor(GPCR), which is widely distributed in the cardiovascular system. This review aims to summarize theGLP-1R dependentsignalingpathwaysinGLP-1cardiovascular protection and related researches, such as theGLP-1R structure, distribution and expression.
Such details provide a deeper understanding and appreciation for Signaling Pathways And Glp-1 Receptor Dispersal.
Here we revisit the actions ofGLP-1, discuss new insights refining cellular localization ofGLP-1R expression, and integrate recent data to refine our understanding of how and whereGLP-1acts to control inflammation, cardiovascular function, islet hormone secretion, gastric emptying, appetite, and body weight.
Highlights recep- Glucagon-like peptide-1receptor1R) spec- plays a pivotal role in regulating lin activa- secretion, glucose homeostasis, satiety, underpinning the and clinical performance and success highlight ofGLP-1R agonists in metabolic do- disorders.
The glucagon-like peptide-1receptor(GLP-1R) is a class B1 G protein-coupledreceptorandmajor therapeutic target in type 2 diabetes and obesity. Beyond its canonical role in Gα s /cAMPsignaling,GLP-1R is increasingly recognized as an organizer of spatiotemporally definedsignalingnanodomains, or "signalosomes."
TheGLP-1signalingpathwayis a layered system that converts a singlereceptor-binding event into coordinated responses across the pancreas, gut, and brain. At the molecular level,receptoractivation triggers cAMP production, which branches into PKA and Epac2pathwaysto control insulin secretion, beta cell gene expression, and cell survival.
